tailieunhanh - Báo cáo y học: " BioBanking - The Holy Grail of novel drug and diagnostic developments"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Wertheim cung cấp cho các bạn kiến thức về ngành y đề tài: BioBanking - The Holy Grail of novel drug and diagnostic developments? | Marko-Varga Journal of Clinical Bioinformatics 2011 1 14 http content 1 1 14 JOURNAL OF CLINICAL BIOINFORMATICS EDITORIAL Open Access BioBanking - The Holy Grail of novel drug and diagnostic developments Gyorgy Marko-Varga1 2 Abstract The ever increasing social cost that society pays for illness and disease are currently steadily increasing in many countries in the world today. These changes in society becomes a major financial burden that activates politicians and health care organizations in order to find new solutions. Biobanks are becoming the new powerful modality within the field of modern Life Science that is expected to be important in the proactive awareness of patient health status. Biobanks are also expected to promote the developments of targeted treatments with personalized indicator assays for effective use of Personalized Medicine treatments in the near future. The reason for these effects of growing health care costs we are experiencing springs from several changes and developments such as increased patient demands patient awareness of quality of life and an increasing global population. Last but not least the increasing number of elderly people and the health care implications for future technology developments are challenges that we need to address in order to be able to be pro-active and build a future plan that meets the resources that will become evident with time. These future developments were recently highlighted in a White Paper by representatives from Pharma industry academic research institutes companies that are technology platform providers and medical health institutions in Japan a country with an expected elderly population of 40 in 2050 1 . We have reached a point where the bioinformatic developments have given us the basis for taking on the sequencing of the Human Proteome that is coded by the genome ever since the last decade when the Human Genome Proj ect was announced by Bill Clinton and Tony Blair as